LabCompass

Sarah Stockman

Medicine · Indiana University

OpenAlex ORCID
Cannabis and Cannabinoid ResearchPI3K/AKT/mTOR signaling in cancerPharmacological Receptor Mechanisms and EffectsNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Publications

10

Citations

63

Est. group size

—

Recurring co-author estimate

Active years

9

Publishing since 2018

Research summary
AI-generated

Sarah Stockman works in biomedical research focused on cancer biology, including how gene expression and cell-signaling pathways relate to cancer outcomes. Recent work spans analysis of ovarian cancer survival from gene expression data and studies of AKT signaling proteins across different cancer types, as well as some contributions to biological data tools. The research combines laboratory cancer biology with computational analysis of biological datasets.

Cancer biology and signaling pathwaysAKT/PI3K/mTOR cell signalingGene expression analysis in cancerComputational and bioinformatic methodsPharmacology and receptor mechanisms

Publication activity has been intermittent over the past decade, with clusters of output in 2018 and again from 2024 onward rather than a steady annual pace.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
172018: 3 publications31819202122232024: 3 publications3242025: 1 publication252026: 3 publications326
Recent publications
Publishes in
  • bioRxiv (Cold Spring Harbor Laboratory)×3
  • Neuropharmacology×2
  • BMC Cancer×1
  • INDIGO (University of Illinois at Chicago)×1
  • Figshare×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile